• STAT+: Poll: Most neurologists and primary care doctors disagree with FDA's approval of Alzheimer's drug

    2 monthes ago - By STAT

    A majority of U.S. physicians disagree with the decision by the Food and Drug Administration to approve the Alzheimer's drug from Biogen and believe the medicine should not be routinely used for patients, according to a new survey from STAT and Medscape.
    In addition, nearly two-thirds of the 200 primary care physicians and neurologists polled said they find the trial data unclear when it comes to the benefits and risks of the drug, which is called Aduhelm. Consequently, only a small minority of these doctors think the medicine should be given to patients with early-onset Alzheimer's, the...
    Read more ...

     

  • Demand is growing for continuous glucose monitoring for type 2 diabetes. Primary care doctors need to prepare

    2 monthes ago - By STAT

    In the last year, Jai Smith has cycled through 13 primary care doctors. Ever since being diagnosed with type 2 diabetes in 1995, she's tried her best to manage a disease that has devastated her family: Her grandmother and four uncles died from its complications.
    But she's struggled to find a doctor in her hometown of Little Rock, Ark., that will give her what she wants to manage the condition: a continuous glucose monitor. Like many patients with diabetes, Smith uses fingerprick glucose tests to help dose her medications. The 44-year-old was immediately interested when she heard about CGM...
    Read more ...